NDC 65862-057 – Nevirapine
Nevirapine Hemihydrate 50 mg/5mL · Suspension · Oral
Product NDC65862-057
Product details
- Brand name
- Nevirapine
- Generic name
- Nevirapine
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- Suspension
- Route
- Oral
- Marketing category
- ANDA · ANDA077702
- Marketed since
- May 22, 2012
- Listing expires
- December 31, 2026
- Pharmacologic class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Nevirapine Hemihydrate 50 mg/5mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 65862-057-11 | 100 mL in 1 BOTTLE (65862-057-11) | May 22, 2012 |
| 65862-057-24 | 240 mL in 1 BOTTLE (65862-057-24) | May 22, 2012 |
Other Nevirapine products
- 65162-209 Nevirapine 200 mg/1 · Tablet · Amneal Pharmaceuticals LLC
- 65862-027 Nevirapine 200 mg/1 · Tablet · Aurobindo Pharma Limited
- 31722-505 Nevirapine 200 mg/1 · Tablet · Camber Pharmaceuticals, Inc.
- 33342-004 Nevirapine 200 mg/1 · Tablet · Macleods Pharmaceuticals Limited
- 33342-238 Nevirapine 400 mg/1 · Tablet, Extended Release · Macleods Pharmaceuticals Limited
- 42571-131 Nevirapine 200 mg/1 · Tablet · Micro Labs Limited
- 0378-4050 Nevirapine 200 mg/1 · Tablet · Mylan Pharmaceuticals Inc.
- 0378-4890 Nevirapine 400 mg/1 · Tablet, Extended Release · Mylan Pharmaceuticals Inc.